Technical Analysis for AVBP - ArriVent BioPharma, Inc.

Grade Last Price % Change Price Change
C 20.10 -0.25% -0.05
AVBP closed down 0.25 percent on Friday, May 17, 2024, on 40 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup -0.25%
Upper Bollinger Band Walk Strength -0.25%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Solid Tumors Cancer Treatment Non Small Cell Lung Cancer Antineoplastic Drugs Lung Cancer Orphan Drug Protein Kinase Inhibitor Tyrosine Kinase Cancer Therapies NSCLC Bemcentinib

Is AVBP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 25.95
52 Week Low 14.35
Average Volume 160,643
200-Day Moving Average 0.00
50-Day Moving Average 17.64
20-Day Moving Average 17.26
10-Day Moving Average 18.37
Average True Range 1.04
RSI (14) 73.54
ADX 21.17
+DI 26.46
-DI 8.64
Chandelier Exit (Long, 3 ATRs) 17.73
Chandelier Exit (Short, 3 ATRs) 17.47
Upper Bollinger Bands 20.10
Lower Bollinger Band 14.43
Percent B (%b) 1.0
BandWidth 32.84
MACD Line 0.60
MACD Signal Line 0.15
MACD Histogram 0.4472
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.39
Resistance 3 (R3) 21.50 21.17 21.18
Resistance 2 (R2) 21.17 20.84 21.12 21.10
Resistance 1 (R1) 20.64 20.64 20.48 20.53 21.03
Pivot Point 20.31 20.31 20.23 20.26 20.31
Support 1 (S1) 19.78 19.98 19.62 19.67 19.17
Support 2 (S2) 19.45 19.78 19.40 19.10
Support 3 (S3) 18.92 19.45 19.03
Support 4 (S4) 18.81